These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23825307)

  • 41. Life after BRCA1/2 testing: family communication and support issues.
    DeMarco TA; McKinnon WC
    Breast Dis; 2006-2007; 27():127-36. PubMed ID: 17917144
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Communication about genetic testing in families of male BRCA1/2 carriers and non-carriers: patterns, priorities and problems.
    Hallowell N; Ardern-Jones A; Eeles R; Foster C; Lucassen A; Moynihan C; Watson M
    Clin Genet; 2005 Jun; 67(6):492-502. PubMed ID: 15857416
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Uptake of genetic counseling among adult children of BRCA1/2 mutation carriers in France.
    Gauna Cristaldo FB; Touzani R; Apostolidis T; Mouret-Fourme E; Stoppa-Lyonnet D; Lasset C; Fricker JP; Berthet P; Julian-Reynier C; Mancini J; Noguès C; Bouhnik AD
    Psychooncology; 2019 Sep; 28(9):1894-1900. PubMed ID: 31276266
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell.
    Patenaude AF; Dorval M; DiGianni LS; Schneider KA; Chittenden A; Garber JE
    J Clin Oncol; 2006 Feb; 24(4):700-6. PubMed ID: 16446344
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing.
    Schwartz MD; Kaufman E; Peshkin BN; Isaacs C; Hughes C; DeMarco T; Finch C; Lerman C
    J Clin Oncol; 2003 Nov; 21(21):4034-41. PubMed ID: 14581427
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study.
    van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; van Gool AR; Klijn JG; Tibben A
    Clin Genet; 2007 Jan; 71(1):35-42. PubMed ID: 17204044
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.
    Katapodi MC; Northouse L; Pierce P; Milliron KJ; Liu G; Merajver SD
    Oncol Nurs Forum; 2011 Sep; 38(5):572-81. PubMed ID: 21875844
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Female family members lack understanding of indeterminate negative BRCA1/2 test results shared by probands.
    Himes DO; Gibbons DK; Birmingham WC; Beckstrand RL; Gammon A; Kinney AY; Clayton MF
    J Genet Couns; 2019 Oct; 28(5):950-961. PubMed ID: 31199558
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Parental communication of BRCA1/2 genetic test results to children.
    Tercyak KP; Hughes C; Main D; Snyder C; Lynch JF; Lynch HT; Lerman C
    Patient Educ Couns; 2001 Mar; 42(3):213-24. PubMed ID: 11164320
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Women receiving news of a family BRCA1/2 mutation: messages of fear and empowerment.
    Crotser CB; Dickerson SS
    J Nurs Scholarsh; 2010 Dec; 42(4):367-78. PubMed ID: 21091619
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Telephoned BRCA1/2 genetic test results: prevalence, practice, and patient satisfaction.
    Baumanis L; Evans JP; Callanan N; Susswein LR
    J Genet Couns; 2009 Oct; 18(5):447-63. PubMed ID: 19462222
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Maternal HIV disclosure to HIV-uninfected children in rural South Africa: a pilot study of a family-based intervention.
    Rochat TJ; Mkwanazi N; Bland R
    BMC Public Health; 2013 Feb; 13():147. PubMed ID: 23418933
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.
    Lerman C; Biesecker B; Benkendorf JL; Kerner J; Gomez-Caminero A; Hughes C; Reed MM
    J Natl Cancer Inst; 1997 Jan; 89(2):148-57. PubMed ID: 8998184
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Randomized comparison of phone versus in-person BRCA1/2 predisposition genetic test result disclosure counseling.
    Jenkins J; Calzone KA; Dimond E; Liewehr DJ; Steinberg SM; Jourkiv O; Klein P; Soballe PW; Prindiville SA; Kirsch IR
    Genet Med; 2007 Aug; 9(8):487-95. PubMed ID: 17700386
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Patient satisfaction of BRCA1/2 genetic testing by women at high risk for breast cancer participating in a prevention trial.
    Klemp JR; O'Dea A; Chamberlain C; Fabian CJ
    Fam Cancer; 2005; 4(4):279-84. PubMed ID: 16341803
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Opinion about reproductive decision making among individuals undergoing BRCA1/2 genetic testing in a multicentre Spanish cohort.
    Fortuny D; Balmaña J; Graña B; Torres A; Ramón y Cajal T; Darder E; Gadea N; Velasco A; López C; Sanz J; Alonso C; Brunet J
    Hum Reprod; 2009 Apr; 24(4):1000-6. PubMed ID: 19112076
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development and testing of a decision aid for breast cancer prevention for women with a BRCA1 or BRCA2 mutation.
    Metcalfe KA; Poll A; O'Connor A; Gershman S; Armel S; Finch A; Demsky R; Rosen B; Narod SA
    Clin Genet; 2007 Sep; 72(3):208-17. PubMed ID: 17718858
    [TBL] [Abstract][Full Text] [Related]  

  • 58. "I Don't Want to Be an Ostrich": Managing Mothers' Uncertainty during BRCA1/2 Genetic Counseling.
    Fisher CL; Roccotagliata T; Rising CJ; Kissane DW; Glogowski EA; Bylund CL
    J Genet Couns; 2017 Jun; 26(3):455-468. PubMed ID: 27473644
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes.
    O'Neill SC; Rini C; Goldsmith RE; Valdimarsdottir H; Cohen LH; Schwartz MD
    Psychooncology; 2009 Oct; 18(10):1088-96. PubMed ID: 19214961
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Short-term psychological impact of the BRCA1/2 test result in women with breast cancer according to their perceived probability of genetic predisposition to cancer.
    Brédart A; Kop JL; Depauw A; Caron O; Sultan S; Leblond D; Fajac A; Buecher B; Gauthier-Villars M; Noguès C; Flahault C; Stoppa-Lyonnet D; Dolbeault S
    Br J Cancer; 2013 Mar; 108(5):1012-20. PubMed ID: 23462725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.